Radoslaw Tarkowski

Radoslaw Tarkowski

Auto-generated profile, based on publicly available information

Radoslaw Tarkowski

Department of Oncology, Division of Surgical Oncology, Wroclaw Medical University, pl. Hirszfelda 12, 53-413, Wrocław, Poland.

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2009 in Psycho-Oncology
Verified
Journal Article
Open access
PDF file
ACAngelika Chachaj
Angelika Chachaj
KMKrzysztof Małyszczak
Krzysztof Małyszczak
KPKrystian Pyszel
Krystian Pyszel
JLJoanna Lukas
Joanna Lukas
RTRadosław Tarkowski
Radosław Tarkowski
ASAndrzej Szuba
Andrzej Szuba
Objective: The aim of the study was to identify factors associated with worse physical and emotional functioning of breast cancer survivors with upper extremity lymphedema.Methods: 1250 sets of questionnaires consisting of WHO‐DAS II, EORTC QLQ‐C30, EORTC QLQ‐BR23 and GHQ‐30 were mailed to women who underwent a breast cancer surgery at the Lower Silesian Oncology Center in Poland between January 1998 and December 2005.Results and conclusions: The response rate was 33.47%. 117 women were included into a lymphedema group and 211 into a group without this complication. Women with lymphedema were more disabled (overall disability (DAS) score 39.78 versus 34.67; p<0.001), reported symptoms from the upper extremity (shoulder or arm pain and difficulties in arm movement) and from the operated breast (pain and swelling) 2–3 times more often, experienced poorer quality of life (global quality of life (QOL) score 0.50 versus 0.57; p=0.005) and higher psychological distress (GHQ score 10.61 versus 8.01; p=0.007) in comparison to breast cancer survivors without lymphedema. The factors associated with higher DAS score, higher GHQ score and lower QOL score in women with lymphedema were as following: pain in the upper limb (mainly shoulder and arm), pain in operated breast, difficulties with arm movement, localization of lymphedema within the hand or in operated breast, a history of dermatolymphangitis and of receiving chemotherapy. Severity of lymphedema, younger age, BMI and localization of lymphedema within the dominant limb were not considerably related to worse outcomes in these women. Copyright © 2009 John Wiley & Sons, Ltd.

5 February 2018 in Journal of Cancer Education
Verified
Journal Article
Closed access
PDF file
PMPaweł Marschollek
Paweł Marschollek
KBKatarzyna Bąkowska
Katarzyna Bąkowska
WBWojciech Bąkowski
Wojciech Bąkowski
KMKarol Marschollek
Karol Marschollek
RTRadosław Tarkowski
Radosław Tarkowski

27 April 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
WWWojciech Wojtowicz
Wojciech Wojtowicz
AWAnna Wróbel
Anna Wróbel
KPKarolina Pyziak
Karolina Pyziak
RTRadosław Tarkowski
Radosław Tarkowski
ABAlicja Balcerzak
Alicja Balcerzak
Piotr MlynarzPiotr Mlynarz
Piotr Mlynarz
Triple-negative breast cancer (TNBC) is characterized by limited survival, poor prognosis, and high recurrence. Understanding the metabolic adaptations of TNBC could help reveal improved treatment regiments. Here we performed a comprehensive 1H NMR metabolic characterization of the MDA-MB-468 cell line, a commonly used model of TNBC, followed by an analysis of serum samples obtained from TNBC patients and healthy controls. MDA-MB-468 cells were cultured, and changes in the metabolic composition of the medium were monitored for 72 h. Based on time courses, metabolites were categorized as being consumed, being produced, or showing a mixed behavior. When comparing TNBC and control samples (HC), and by using multivariate and univariate analyses, we identified nine metabolites with differing profiles). The serum of TNBC patients was characterized by higher levels of glucose, glutamine, citrate, and acetoacetate and by lower levels of lactate, alanine, tyrosine, glutamate, and acetone. A comparative analysis between MDA-MB-468 cell culture media and TNBC patients’ serum identified a potential systemic response to the carcinogenesis-associated processes, highlighting that MDA-MB-468 cells footprint does not reflect metabolic changes observed in studied TNBC serum fingerprint.

17 October 2015 in Journal of Cancer Education
Verified
Journal Article
Open access
PDF file
JNJonatan Nowakowski
Jonatan Nowakowski
GBGrazyna Borowiec
Grazyna Borowiec
IZIzabela Zwierz
Izabela Zwierz
WJWojciech Jagodzinski
Wojciech Jagodzinski
RTRadoslaw Tarkowski
Radoslaw Tarkowski
Burnout is a serious problem facing the majority of oncologists. Many medical students may regard oncology as depressive part of medicine. This false picture may discourage them from choosing oncology as their future specialization. To learn problems experienced by oncologists and to answer the students’ question: is it dangerous to choose oncology? We conducted an anonymous survey among 69 oncologists. Young doctors (up to 5 years of service) accounted for 31 %, specialists 69 %, with a median length of practice of 14 years. The most frequently reported symptoms included irritability (84 %) and tension (74 %). Forty-five percent reported headaches, 25 % sleep disorders, 51 % negative impact on their personal lives. Excessive bureaucratization, overwork, and haste, with the disparity between undertaken effort and compensation were the most common sources of stress. Stress reduction methods were as follows: their relationship with family and/or friends (69 %), reading books/watching movies (66 %), emotional distance from their problems (63 %), and contact with nature (62 %). Ninety-six percent of physicians were satisfied with their choice of pursuing work with cancer patients. However, as many as 49 % of oncologists experienced moments of doubt regarding their sense of vocation. Students and young doctors considering pursuing an oncological speciality should not be discouraged by the likely degree of sacrifice or burden, but rather aim to develop effective ways to reduce stress, along with remembering one’s own health needs. This could be valuable part of both pregradual and postgradual medical education, worth to become part of medical curricula.

21 January 2016 in Journal of Cancer Education
Verified
Journal Article
Open access
PDF file
RTR. Tarkowski
R. Tarkowski
KSK. Szmigiel
K. Szmigiel
ARA. Rubin
A. Rubin
GBG. Borowiec
G. Borowiec
JSJ. Szelachowska
J. Szelachowska
MBM. Bębenek
M. Bębenek
Breast reconstruction (BR) should be offered and discussed to each woman with breast cancer who planned for mastectomy, except the cases with severe comorbidities. However, the majority of these patients do not undergo reconstructive surgery. A 20-question survey was administered to a group of 50 women (age 29–83 years, median 53) treated with mastectomy. 22.4 % underwent reconstruction of the breast, 24.5 % declared an interest in BR in the future, 53.1 % were not interested in reconstructive surgery. 51.2 % obtained information concerning BR before surgery, 58.1 % after and 44.2 % both before and after mastectomy. 59.2 % were informed about reimbursement. Information given before surgery had a statistically significant impact on performing reconstruction or a declared interest in BR (X 2 = 4.950, df = 1, p < 0.05), as well as information about reimbursement (X 2 = 8.875, df = 1, p < 0.05). Age <55 years was another significant factor (X 2 = 13.522, df = 1, p < 0.05, C Pearson = 0.525). Level of education did not impact upon the choice (p > 0.05). The main reasons for the refusal were fear of complications (47.4 %), priority to recovery over aesthetic (36.8 %), age, defined by the patient as “advanced” (31.6 %), high level of acceptance of the body after amputation (31.6 %), fear of cancer recurrence (26.3 %) and fear of the pain and discomfort (15.8 %). Each patient who planned for mastectomy should obtain sufficient information regarding breast reconstruction. Exact information is of special benefit to women discouraged by imagined disadvantages of surgery. Patients’ education impacts the quality of life—not only before surgery but also lifelong after finishing the treatment.

12 December 2013 in Journal of Cancer Education
Verified
Journal Article
Open access
PDF file
RTRadoslaw Tarkowski
Radoslaw Tarkowski
JKJan Kornafel
Jan Kornafel
The incidence of cancer continues to rise, and despite the development of prevention and treatment strategies, tumour burden still remains a major problem. Many may ask “who becomes an oncologist?” The answer is generally one who believes they can help and who believes in possibilities of oncologic treatment. Unfortunately, there are a large proportion of medical students who consider oncology as palliative care or at least a depressive branch of medicine which gives no hope and causes burn out syndrome rather quickly. Should we endeavour to change their point of view while studying at the medical universities? Of course, yes.